| Clinical applications of mesenchymal stem cells in chronic diseases A Farini, C Sitzia, S Erratico, M Meregalli, Y Torrente Stem cells international 2014 (1), 306573, 2014 | 160 | 2014 |
| Covid-19-associated coagulopathy: biomarkers of thrombin generation and fibrinolysis leading the outcome M Ranucci, C Sitzia, E Baryshnikova, U Di Dedda, R Cardani, F Martelli, ... Journal of clinical medicine 9 (11), 3487, 2020 | 85 | 2020 |
| Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy C Godi, A Ambrosi, F Nicastro, SC Previtali, C Santarosa, S Napolitano, ... Annals of clinical and translational neurology 3 (8), 607-622, 2016 | 73 | 2016 |
| NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis L Anastasia, N Papini, F Colazzo, G Palazzolo, C Tringali, L Dileo, ... Journal of Biological Chemistry 283 (52), 36265-36271, 2008 | 66 | 2008 |
| Perspectives of stem cell therapy in D uchenne muscular dystrophy M Meregalli, A Farini, M Belicchi, D Parolini, L Cassinelli, P Razini, ... The FEBS journal 280 (17), 4251-4262, 2013 | 53 | 2013 |
| Therapeutic potential of immunoproteasome inhibition in Duchenne muscular dystrophy A Farini, C Sitzia, B Cassani, L Cassinelli, R Rigoni, F Colleoni, N Fusco, ... Molecular Therapy 24 (11), 1898-1912, 2016 | 47 | 2016 |
| Advancements in stem cells treatment of skeletal muscle wasting M Meregalli, A Farini, C Sitzia, Y Torrente Frontiers in physiology 5, 48, 2014 | 43 | 2014 |
| Fibrosis rescue improves cardiac function in dystrophin-deficient mice and Duchenne patient–specific cardiomyocytes by immunoproteasome modulation A Farini, A Gowran, P Bella, C Sitzia, A Scopece, E Castiglioni, D Rovina, ... The American journal of pathology 189 (2), 339-353, 2019 | 36 | 2019 |
| Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy F D’Avila, M Meregalli, S Lupoli, M Barcella, A Orro, F De Santis, C Sitzia, ... Journal of muscle research and cell motility 37, 101-115, 2016 | 33 | 2016 |
| Soluble receptor for advanced glycation end products and its forms in COVID-19 patients with and without diabetes mellitus: a pilot study on their role as disease biomarkers E Dozio, C Sitzia, L Pistelli, R Cardani, R Rigolini, M Ranucci, ... Journal of Clinical Medicine 9 (11), 3785, 2020 | 32 | 2020 |
| PCSK9 expression in epicardial adipose tissue: molecular association with local tissue inflammation E Dozio, M Ruscica, E Vianello, C Macchi, C Sitzia, G Schmitz, L Tacchini, ... Mediators of Inflammation 2020 (1), 1348913, 2020 | 32 | 2020 |
| Adaptive immune response impairs the efficacy of autologous transplantation of engineered stem cells in dystrophic dogs C Sitzia, A Farini, L Jardim, P Razini, M Belicchi, L Cassinelli, C Villa, ... Molecular Therapy 24 (11), 1949-1964, 2016 | 32 | 2016 |
| Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model A Farini, C Sitzia, C Navarro, G D'Antona, M Belicchi, D Parolini, ... Experimental cell research 318 (10), 1160-1174, 2012 | 32 | 2012 |
| Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle A Farini, C Sitzia, L Cassinelli, F Colleoni, D Parolini, U Giovanella, ... Development 143 (4), 658-669, 2016 | 30 | 2016 |
| Preliminary evidences of safety and efficacy of flavonoids-And omega 3-based compound for muscular dystrophies treatment: a randomized double-blind placebo controlled pilot … C Sitzia, M Meregalli, M Belicchi, A Farini, M Arosio, D Bestetti, C Villa, ... Frontiers in Neurology 10, 462239, 2019 | 28 | 2019 |
| Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy P Bella, A Farini, S Banfi, D Parolini, N Tonna, M Meregalli, M Belicchi, ... EMBO molecular medicine 12 (1), e11019, 2020 | 24 | 2020 |
| Novel insight into stem cell trafficking in dystrophic muscles A Farini, C Villa, A Manescu, F Fiori, A Giuliani, P Razini, C Sitzia, ... International journal of nanomedicine, 3059-3067, 2012 | 21 | 2012 |
| Influence of immune responses in gene/stem cell therapies for muscular dystrophies A Farini, C Sitzia, S Erratico, M Meregalli, Y Torrente BioMed research international 2014 (1), 818107, 2014 | 20 | 2014 |
| Full‐length dysferlin expression driven by engineered human dystrophic blood derived CD 133+ stem cells M Meregalli, C Navarro, C Sitzia, A Farini, E Montani, N Wein, P Razini, ... The FEBS Journal 280 (23), 6045-6060, 2013 | 18 | 2013 |
| PTX3 predicts myocardial damage and fibrosis in Duchenne muscular dystrophy A Farini, C Villa, D Di Silvestre, P Bella, L Tripodi, R Rossi, C Sitzia, ... Frontiers in Physiology 11, 403, 2020 | 17 | 2020 |
